SCHEMBL3876701

SCHEMBL3876701

Cc1cc(N(CCO)CCO)c2sc3ccccc3c2c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.36
MAPT P10636 8/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
POLB P06746 3/20 0.36
LMNA P02545 3/20 0.36
HCRTR1 O43613 1/20 0.36
CHRM2 P08172 2/20 0.33
HTR1A P08908 2/20 0.33
ADRA2A P08913 2/20 0.33
CHRM1 P11229 2/20 0.33
TBXA2R P21731 2/20 0.33
SLC6A2 P23975 2/20 0.33
APEX1 P27695 2/20 0.33
SLC6A4 P31645 2/20 0.33
ADRA1A P35348 2/20 0.33
OPRM1 P35372 2/20 0.33
DRD3 P35462 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KCNH2 Q12809 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885302 0.90 ALDH1A1 (0.36) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3878213 0.89 ALDH1A1 (0.37) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3880854 0.79 LIMK1 (0.36) ALDH1A1MAPTPOLBLMNACHRM2
SCHEMBL3882573 0.78 ALDH1A1 (0.33) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3879167 0.78 CYP2C19 (0.40) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3875295 0.76 LIMK1 (0.36) ALDH1A1MAPTPOLBLMNACHRM2
SCHEMBL3876862 0.76 MAPT (0.39) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3875198 0.76 MAPT (0.46) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3873730 0.75 ALDH1A1 (0.32) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL3882583 0.75 ALDH1A1 (0.44) ALDH1A1MAPTL3MBTL1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US claimed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US claimed
US-7491245-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2009-02-17 US disclosed
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US disclosed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US disclosed
EP-1735059-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-12-27 EP disclosed
WO-2005099656-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-10-27 WO disclosed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, TUBB6 ALDH1A1 660/4885MAPT 420/4885L3MBTL1 4308/4885
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, TUBB6 ALDH1A1 660/4885MAPT 420/4885L3MBTL1 4308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.